Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TRV130 for Acute Pain from Long Bone Fracture
NCT02520297Phase 2Terminated
- Sponsor
- Trevena, Inc.
- Start
- Oct 2015
- Primary completion
- Oct 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of oliceridine in acute pain, sponsored by Trevena, Inc.. Started Oct 2015; status: terminated.
02
Drugs
oliceridine
03
Conditions
acute pain
Beyond the preview
Go deeper on NCT02520297.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02520297.